Novel Macrocyclic LRRK2 Inhibitors for Treating Parkinson's Disease

被引：1
|
作者：
Sabnis, Ram W. [1 ]
机构：
[1] Smith Gambrell & Russell LLP, Atlanta, GA 30309 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2022年
关键词：
D O I：
10.1021/acsmedchemlett.1c00687
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Metabolomic analysis in LRRK2 Parkinson's disease
    Johansen, K. K.
    Matson, W.
    Beal, F.
    Aasly, J. O.
    Bogdanov, M.
    MOVEMENT DISORDERS, 2007, 22 : S187 - S187
  • [22] Identification of LRRK2 mutations in Parkinson's disease
    Lewthwaite, A. J.
    Nicholl, D. J.
    Morrison, K. E.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (12): : 1397 - 1397
  • [23] LRRK2 at the Crossroad of Aging and Parkinson's Disease
    Hur, Eun-Mi
    Lee, Byoung Dae
    GENES, 2021, 12 (04)
  • [24] Analysis of LRRK2 variants in Parkinson's disease
    Au, W. L.
    Ho, P.
    Zhao, Y.
    Tan, L. C. S.
    Tan, E. K.
    MOVEMENT DISORDERS, 2010, 25 (07) : S468 - S468
  • [25] Mutations in LRRK2 as a cause of Parkinson's disease
    Giasson, Benoit I.
    Van Deerlin, Vivianna M.
    NEUROSIGNALS, 2008, 16 (01) : 99 - 105
  • [26] LRRK2 is reduced in Parkinson’s disease gut
    Adrien de Guilhem de Lataillade
    Jérémy Verchere
    Thibauld Oullier
    Alice Prigent
    Tony Durand
    Carolina Pellegrini
    Michel Neunlist
    Thierry Baron
    Malvyne Rolli-Derkinderen
    Pascal Derkinderen
    Acta Neuropathologica, 2021, 142 : 601 - 603
  • [27] LRRK2 is reduced in Parkinson's disease gut
    de Guilhem de Lataillade, Adrien
    Verchere, Jeremy
    Oullier, Thibauld
    Prigent, Alice
    Durand, Tony
    Pellegrini, Carolina
    Neunlist, Michel
    Baron, Thierry
    Rolli-Derkinderen, Malvyne
    Derkinderen, Pascal
    ACTA NEUROPATHOLOGICA, 2021, 142 (03) : 601 - 603
  • [28] The Cell Biology of LRRK2 in Parkinson's Disease
    Usmani, Ahsan
    Shavarebi, Farbod
    Hiniker, Annie
    MOLECULAR AND CELLULAR BIOLOGY, 2021, 41 (05)
  • [29] Lrrk2 pathogenic substitutions in Parkinson's disease
    Mata, IF
    Kachergus, JM
    Taylor, JP
    Lincoln, S
    Aasly, J
    Lynch, T
    Hulihan, MM
    Cobb, SA
    Wu, RM
    Lu, CS
    Lahoz, C
    Wszolek, ZK
    Farrer, MJ
    NEUROGENETICS, 2005, 6 (04) : 171 - 177
  • [30] Identification of novel mutations in LRRK2 gene in patients with Parkinson's disease
    Jankovic, M.
    Kresojevic, N. D.
    Dobricic, V.
    Markovic, V.
    Petrovic, I.
    Novakovic, I.
    Kostic, V. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 354 - 354
12345